Evidence map›Paper›PMID 34615682›Full record

ArticleBMJ open2021

Clinical features and diagnosis of multiple myeloma: a population-based cohort study in primary care.

Anouchka Seesaghur, Natalia Petruski-Ivleva, Victoria Louise Banks, Jocelyn Ruoyi Wang, Ali Abbasi, David Neasham, Karthik Ramasamy

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Anouchka SeesaghurCenter for Observational Research (CfOR), Amgen Ltd, Uxbridge, UK.ORCID 0000-0003-2997-5867
Natalia Petruski-IvlevaScience, Aetion, Inc, Boston, Massachusetts, USA.
Victoria Louise BanksCenter for Observational Research (CfOR), Amgen Ltd, Uxbridge, UK.
Jocelyn Ruoyi WangScience, Aetion, Inc, Boston, Massachusetts, USA.
Ali AbbasiCenter for Observational Research (CfOR), Amgen Ltd, Uxbridge, UK.
David NeashamCenter for Observational Research (CfOR), Amgen Ltd, Uxbridge, UK.
Karthik RamasamyDepartment of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK karthik.ramasamy@ndcls.ox.ac.uk.
Amgen (United Kingdom) · GBAetion (United States) · USOxford University Hospitals NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPatients with multiple myeloma (MM) experience significant delays in diagnosis due to non-specific symptomatology. The aim of this study was to characterise the frequency and timing of clinical features in the primary care setting prior to MM diagnosis.

designPopulation-based cohort study.

settingElectronic health records data of approximately 17 million patients (2006-2016) within the UK Clinical Practice Research Datalink.

participantsPatients aged ≥18 years with newly diagnosed MM (NDMM), no history of solid tumours and ≥2 years registration in a primary care practice prior to MM diagnosis.

main outcome measuresClinical features and symptoms including bone pain, skeletal-related events (SREs), investigation and confirmation of MM diagnostic CRAB criteria (hyperCalcaemia, Renal impairment, Anaemia, Bone lesions) during the 2 years prior to MM diagnosis; time between symptom manifestation and/or relevant investigation and diagnosis of MM.

resultsAmong 2646 patients with NDMM, 47.5% had a bone pain record during the 2-year period prior to MM diagnosis, mainly affecting the back. Regardless of baseline bone pain, investigations for serum calcium level were used in 36.4% of patients prior to MM diagnosis, followed by haemoglobin (65.6%) or renal function (74.1%). Median (Q1, Q3) time from first-recorded bone pain to MM diagnosis was 220 (80, 476) days. Median (Q1, Q3) time from first-recorded hypercalcaemia, renal impairment or anaemia to MM diagnosis was 23 (12, 46), 58 (17, 254) and 73 days (28, 232), respectively. An imaging investigation or referral for imaging was recorded for 60.0% of patients with bone pain/SRE and 32% without.

conclusionsNearly half of patients diagnosed with NDMM presented with bone pain approximately 7 months prior to MM diagnosis. Investigations to evaluate all CRAB criteria, including targeted imaging, were underused. Early recognition of myeloma clinical features and optimised use of investigations in primary care may potentially expedite MM diagnosis.

Indexed as

Bone DiseasesMultiple MyelomaRenal InsufficiencyAdolescentAdultCohort StudiesHumansPrimary Health Careepidemiologymyelomaprimary care

Identifiers

PMID34615682
PMCPMC8496401
OpenAlexW3202955607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.